Device for skin or tissue treatment
Patent Information
- Application Number
- PCT/EP2023/064832
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-06-02
- Publication Date
- 2024-12-05
Smart Images

Figure EP2023064832_05122024_PF_FP_ABST
Abstract
Description
[0001] TITLE
[0002] DEVICE FOR SKIN OR TISSUE TREATMENT
[0003] TECHNICAL FIELD
[0004] The present invention relates to a device for skin or tissue treatment with radiofrequency (RF) energy and a method for operating the device.
[0005] PRIOR ART
[0006] Skin or tissue diseases, skin lesions and abnormal tissue can be treated with hyperthermia methods. One example is the use of an RF energy source. In this method, an alternating electromagnetic field penetrates the skin including the deep skin layers and intrudes heat via dielectric and conductive losses. The thermal dose is defined through temperature level and exposure time. The thermal dose is applied by using an RF applicator.
[0007] Care has to be taken that the treated skin or tissue is not overheated, which may cause permanent damage to the skin. Undesired temperature overshoot especially occurs during ram-up of the system. However, using a low temperature may result in insufficient treating the patient. Some skin areas which need treatments are too large to be treated by one application only, so that the RF applicator has to be moved treating one part of the area after the other. Care has to be taken that overlapping regions of the treated parts of the area is not overheated and does not distort the temperature control of the system.
[0008] US 8 306 629 B2 discloses a hyperthermia treatment device and method using RF energy considering these needs. The device comprises a control unit with an RF module and a handset with a plug-in applicator comprising two probes. The probes are pressed against abnormal skin or tissue. RF energy is conducted from a first of these probes through the abnormal skin or tissue to the other probe in order to elevate the temperature in the skin or tissue to a selected value and then maintain it at the selected value for a predetermined time. The device comprises a temperature sensor which is used to control the temperature of the treatment site during temperature ramp-up to the selected value. The sensor also assists in maintaining temperature within a range of desired temperature during treatment of the skin or tissue.
[0009] The temperature sensor of US 8 306 629 B2 is a thermocouple located in the first probe which is connected a "hot" conductor. The second probe is connected to a ground shield conductor. The probes are hollow. The temperature sensor measures the temperature of the first probe. It is also mentioned that the thermal sensor can be attached to the applicator in some other fashion so as to thermally contact the treatment site.
[0010] The device described in US 8 306 629 B2 is on the market using the name "ThermoMed". This device is quite expensive. Having the sensor built into one of the probes (also called electrodes), the device only experiences a temperature change with a delay, since the heat travels the long way from the skin via the electrodes to the sensor. In addition, the losses that occur on the way lead to a falsified measurement result. The sensor rather measures the temperature of the electrode heated up by the skin than the skin temperature itself.
[0011] US 2011 / 096438 A1 describes a device for subcutaneous adipose tissue skin treatment applying both RF and ultrasound energy (US) into the skin from a single electrode. The electrode is arranged within a handpiece. It only protrudes slightly from the surface of the handpiece in a convex shape. An infrared temperature sensor is present within the handpiece as well, wherein it is located at a distance to the electrode. For treatment, an electrically conductive gel is applied to the patient's skin at the treatment site, and a passive electrode is attached to the patient's body opposite the treatment site.
[0012] "Skin" in this text therefore means "skin and / or tissue". Sometimes the expressions "skin and tissue" or "skin or tissue" are used to emphasize that skin and tissue can both be treated. The expressions have to be understood such that skin and / or tissue can be treated.
[0013] Skin treatment includes treatment for any abnormality, ailment, condition, disease, disorder, wound or the like.
[0014] SUMMARY OF THE INVENTION
[0015] It is an object of the invention to provide a treatment device for skin or tissue treatment with radiofrequency (RF) energy and a method for operating the device which improves safety with regard to overheating the treated skin or tissue area.
[0016] This object is solved by a treatment device for skin or tissue treatment with radiofrequency (RF) energy comprising a control unit and a handset device. The handset device comprises a handset with a handset housing and an applicator, wherein the applicator comprises two elongate electrodes to be applied to the skin or tissue to be treated. The treatment device further comprises a temperature sensor for detecting a temperature at a treatment site, wherein the control unit controls the RF energy according to the detected temperature at the treatment site. According to the invention, the temperature sensor is a contactless sensor.
[0017] "contactless" means that the sensor does not have to touch or contact the skin or tissue for detecting or measuring the temperature of the skin or tissue directly.
[0018] The treatment device according to the invention ensures that the RF energy applied does not overheat the skin or tissue. This is ensured by measuring at the location of treatment and by measuring the temperature of the skin or tissue directly, enabling an almost delay- free collection of data informing about the skin or tissue temperature. Preferably, the surface temperature is measured.
[0019] The inventive device is especially suitable for treatment of Cutaneous Leishmaniasis (CL). This is a neglected skin disease with about 12 million people currently infected, especially in South America, Africa and Asia. There are up to 2 million new cases yearly. Drug treatment exists, such as Pentavalent Antimonials and Miltefosine. However, the sideeffects may be severe, such as Pancreatitis, Leukopenia, Thrombocytopenia or even death.
[0020] The inventive device may also be used for other non-invasive treatment of skin or tissue, which also may include Actinic Keratosis, Angioma, Acrochordon, Atypical Mycobacteria, Buruli ulcer, Chromoblastomycosis, Cystic Acne, Clavus, Dermatophytosis, Epidermoid Cysts, Fibroma, Hydrocystoma, Keloids, Molluscum Contagiosum, Mycetoma, Seborrheic Keratosis, Sporotrichosis, Syringoma and Warts.
[0021] The inventive device can be used for cosmetic or aesthetics or wellness treatments as well.
[0022] In preferred embodiments, the temperature sensor is arranged such that it detects or measures an area between the two electrodes. In more preferred embodiments, the temperature sensor is arranged that it measures exclusively between the two electrodes except a periphery of the two electrodes. Most preferred, the temperature sensor is arranged that it measures exclusively between the two electrodes with a distance to the two electrodes. These three embodiments ensure, with increasingly better result depending on their preference, that the measurement is not falsified by a delay or heat loss cause by the heating up the electrodes. This is especially important during ramp-up when the electrodes are not yet heated to an operating temperature.
[0023] Preferably, the two electrodes are identical. This includes that they have the same lengths, the same thickness, the same cross-section over their entire length, and that they are made of the same material and have the same surface treatment. RF energy may be delivered in a uniform way by at least two active electrodes. A uniform heating over an entire treatment area is enabled. This improves safety as well. In addition, efficacy and performance is improved.
[0024] Preferably, the electrodes have a circular cross-section. Preferably, the size and shape of the cross-section remains the same at least along the area of the electrodes, which is applied on the patient's skin.
[0025] The treatment area, also called treatment site, is preferably the area defined by the lengths of the skin contacting parts of the electrodes and the distance between these two parts of the two electrodes. A uniform heating simplifies the control and reduces the risk of overheating or burning the treated skin.
[0026] Preferably, the sensor measures or detects the temperature within this uniform treatment area. More preferably, the sensor measures or detects the temperature almost in the whole treatment area.
[0027] In preferred embodiments, the two electrodes are operated simultaneously and identically. This enables a uniform treatment area as well. The uniformity is enhanced when the electrodes are in addition identical.
[0028] Preferably, both electrodes are active electrodes. The two electrodes are preferably electrically balanced.
[0029] 'Active" means that a RF signal is carried through the electrode. The RF-amplifier drives an electrode's voltage with respect to a common ground.
[0030] Providing two active electrodes or having only active electrodes enables to keep the same voltage magnitude, but unequal signs between each of the electrodes and a common ground. The common ground could by virtual. As a result, the RF currents through both electrodes are of equal magnitude, too. The two electrodes are therefore electrically balanced. Driving the electrodes balanced (i.e., electrically symmetrical) ensures that the tissue between the electrodes is heated in a symmetrical pattern or even better uniformly.
[0031] It has been found that a uniform heating over the entire treatment area can be obtained when the two electrodes are massive, which means not hollow. Preferably, the two electrodes are made of the same material over their entire length, and preferably over their entire diameter.
[0032] In preferred embodiments, the two electrodes define an area to contact the skin or tissue to be treated simultaneously, wherein the area is preferably about 70 mm2to 80 mm2and more preferably about 76 mm2or about 19 mm to 4 mm.
[0033] In preferred embodiments, each of the two electrodes comprises a first leg connected to the handset housing and extending from the handset housing and a second leg extending at an angle to the first leg. At least the second legs of the two electrodes extend parallel to each other. The second legs of the two electrodes are suitable to be applied to the skin or tissue to be treated simultaneously. Preferably, the second legs extend in a straight line. Preferably, the second legs are suitable to be applied to the skin or tissue to be treated along their whole length.
[0034] This shape allows to contact a well-defined region of the skin to be treated. The treatment area has preferably the shape of a rectangle and it is defined by the space between the two parts of the electrode, which lay on the skin. The detection or measurement area of temperature sensor is preferably an ellipse which is slightly smaller than this treatment area.
[0035] In some embodiments, a third or even a fourth or more electrodes are present. They may be identical with the first two electrodes or they may be different. They may be active or not active. However, in most preferred embodiments, exactly two electrodes are present. The use of two electrodes simplifies the control and enables a uniform heating area. The contactless temperature sensor can be any kind of sensor suitable to measure temperature of the skin directly without having to contact the skin. In preferred embodiments, the contactless temperature sensor is an infrared sensor. This sensor can be placed near the electrodes and is able to measure the temperature of the skin with a sufficient accuracy to enable an optimized control of the RF energy applied.
[0036] Preferably, the temperature sensor is arranged in the handset device at a distance to the two electrodes and located in a middle axis between the two electrodes. This enables a perfect measurement area which overlaps with the treatment area in an optimized way.
[0037] In preferred embodiments, the handset comprises the temperature sensor: Preferably it is arranged in the handset housing. Sufficient space is therefore provided for the sensor electronics. Furthermore, the temperature sensor remains at its place when the electrodes are changed or removed.
[0038] Preferably, the applicator comprises a plug holding the two electrodes, wherein the plug is removable connectable to the handset housing. This enables using the same handset for different types of treatments. In addition, worn-out electrodes or electrodes which have to be removed for hygienic reasons, can easily be exchanged. When the temperature sensor is located within the handset housing and not within the applicator, this reduces the costs for the exchangeable applicator.
[0039] Preferably, the temperature set point can be adjusted, which opens the possibility to market the device for further high-frequency applications such as wrinkle and cellulite treatment or other treatments mentioned above.
[0040] Preferably, the control unit comprises means for obtaining three inputs, wherein the control unit comprises a control algorithm for evaluating the three inputs and wherein the three inputs are power output, measured temperature, and measured impedance.
[0041] Preferably, the control unit comprises means to measure a first voltage across the electrodes and a second voltage, the second voltage being the drop across a shunt resistor in a current path leading back from the electrodes to the control unit. The control unit preferably further comprises means for comparing curves of the first and second voltage by use of a phase locked loop, resulting in a voltage depending on the phase angle. This resulting voltage can be used to control the RF energy applied to the electrodes. This is a quite fast, secure, and efficient way to control the temperature at the treatment site.
[0042] Preferably, the control unit comprises means to deduct the impedance of at least some parts of an electronic circuit of the control unit from the measured impedance in order to obtain a corrected impedance, wherein this corrected impedance is used as one of the three inputs.
[0043] The impedance is usually measured between the two electrodes at a first frequency. The first frequency is preferably the treatment frequency. In case the treatment device has different treatment frequencies, all of them are preferably the first frequency.
[0044] In some embodiments, the treatment device is capable of being operated at least one second frequency being different to the first frequency and wherein at least one second impedance is measured at the at least one second frequency.
[0045] The means mentioned are the micro-controller and in some embodiments some circuits of the control unit, especially of the RF module.
[0046] The treatment device described above is preferably used for treating Cutaneous Leishmaniasis.
[0047] An inventive method for operating the inventive treatment device comprises applying a RF energy to two elongate electrodes, using a contactless temperature sensor for detecting a temperature at a treatment site and controlling the RF energy according to the detected temperature at the treatment site.
[0048] Preferably the method comprises the step of obtaining three inputs and evaluating the three inputs in a control algorithm, the three inputs being power output, measured temperature and measured impedance and the step of controlling the RF energy applied to the two electrodes based on the evaluation of the three inputs.
[0049] Preferably, two voltages are measured. The first voltage is the voltage across the electrodes, i.e. , the voltage across the skin. The second voltage is the voltage drop across a shunt resistor in the current path leading back from the electrodes. These voltage curves are compared by use of a phase locked loop which results in a voltage depending on the phase angle. The measured impedance comprises the impedance of the skin or tissue and some parts of the electronic circuit. These parts are deducted from the measured value afterwards.
[0050] The skin impedance is the electrical impedance of the skin that is measured between the two electrode interfaces. It is a measure of how much the skin tissue opposes current flow when a voltage is applied to the electrodes at a given frequency. The frequency is preferably 6.78 MHz. Preferably, this is the treatment frequency.
[0051] The measured impedance does also inform about the time shift between current and voltage waveforms (called phase). The skin impedance is a more general form of resistance.
[0052] Knowing the skin resistance has two advantages:
[0053] - it can be used to better control the power, and with that the temperature and
[0054] - it can be used to detect incorrect operating conditions.
[0055] In addition, it informs about the skin condition, for example its water content (hydration).
[0056] In some embodiments, the impedance measurement is expanded to at least one other frequency or to a multiple of other frequencies (spectrum) instead of just the single one used for the RF heating. This gives more information about the skin condition.
[0057] The inventive device minimizes the risk of overheating a patient's skin, especially during ramp-up. Efficacy of the treatment can be increased. Due to the components chosen, the device can be produced at low costs, and it can therefore be sold to an affordable price, even in developing countries. By improving patient safety and lowering the costs for production, the treatment device creates an affordable alternative to drug treatment with its side-effects. Quality of life for patients is improved.
[0058] Further embodiments of the invention are laid down in the dependent claims.
[0059] BRIEF DESCRIPTION OF THE DRAWINGS
[0060] A preferred embodiment of the invention is described in the following with reference to the drawings, which are for the purpose of illustrating the present preferred embodiments of the invention and not for the purpose of limiting the same. In the drawings, Figure 1 shows a treatment device for skin treatment with RF energy according to the invention;
[0061] Figure 2 shows a handset device of the device according to figure 1 in a perspective view;
[0062] Figure 3 shows a longitudinal cross-section of the handset device according to figure 2;
[0063] Figure 4 shows the handset device according to figure 2 in an exploded view;
[0064] Figure 5 shows a side view of an electrode of the handset device according to figure 2;
[0065] Figure 6 shows a top view of the electrode according to figure 5;
[0066] Figure 7 shows a schematic view of a front part of an applicator of the handset device according to figure 2, applicated on a skin zone of a patient and in use;
[0067] Figure 8 shows a graph of a skin temperature of the skin in the region of the two electrodes;
[0068] Figure 9 shows graphs of a skin temperature at ramp-up of the inventive device compared to a state-of-the-art device;
[0069] Figure 10 shows a block diagram of an RF module of the treatment device according to figure 1;
[0070] Figure 11 shows a block diagram of the handset device;
[0071] Figure 12 shows a flow chart depicting the security control routine of the control unit during treatment;
[0072] Figure 13 shows a flow chart depicting the ramp-up and operation mode of the control unit and
[0073] Figure 14 shows a flow chart depicting the updating of the control unit with new data. DESCRIPTION OF PREFERRED EMBODIMENTS
[0074] Figure 1 shows a preferred embodiment of the inventive treatment device for skin or tissue treatment with RF energy. The device is especially suitable for treatment of Cutaneous Leishmaniasis (CL), but it can be used for other treatment, including cosmetic, aesthetics or wellness treatments as well.
[0075] The device comprises a control unit 1 for supplying and controlling the RF energy, a handset device 3 for applying the RF energy to a skin of a patient and a supply line 2 connecting the control unit 1 with the handset device 3.
[0076] The control unit 1 is preferably portable. The control unit 1 may be battery powered and / or may be connectable to a power grid. The control unit 1 comprises a housing 10, control means 11 , for example an activation and adjustment knob, and a display 12. The treatment device may connect by wire or wireless to other devices to exchange data that may be collected on the treatment device during application.
[0077] The handset device 3, as shown in figures 2 to 4, comprises a handset housing 30 and an applicator 31. The applicator 31 may be permanently connected to the handset housing 30. Preferably, the applicator 31 comprises a plug 32 to be releasable connectable to the handset housing 30. The applicator 31 comprises two electrodes 33, which are permanently or releasable connected to the plug 31.
[0078] The handset device 3 also comprises a contactless temperature sensor 34, which is preferably an infrared sensor. The temperature sensor 34 is arranged in the front side of the handset housing 30. In other embodiments, it may be arranged in the plug 32.
[0079] Indentations 300 and / or areas with gripping surfaces on handset the housing 30 ensure a secure grip when the handset device is held in a physician's or another user's hand.
[0080] The handset device 3 comprises an actuator 38, in this example a pushbutton or a switch, so that the user can activate the treatment when he / she holds the handset device and after having applied the electrodes 33 on a patient's skin. The actuator 38 preferably protrudes the handset housing 30 on the top of the housing 30 in a front area. This enables the user to start the treatment by just using one finger, preferably the index finger, thereby holding the handset device firmly in his / her hand. The handset housing 30 consists of a first and second housing part 30', 30". They can be permanently connected to each other, for example by latching or snapping means. In this example, the first housing part 30 comprises bushes 304 and the second housing part 30" comprises through bores 308, so that the two housing parts 30, 30' can be connected with screws 35 and locknuts 350.
[0081] An electronic module 36 is arranged within the handset housing 30. The electronic module 36 is fixed to a fixation plate 305 formed in one piece with the first housing part 30'. In this example, screws 306 and locknuts 307 are used for fixation.
[0082] A module connector 360 is fixed to the electronic module 36 and extends to an end face opening 309 of the handset housing 30. The module connector 360 is coupled to the supply line 2.
[0083] A fist receptacle part 301 and a second receptacle part 30T arranged in the first and second housing part 30', 30" respectively form a receptacle for receiving the plug 32 of the applicator 31. A first window part 302 and a second window part 302' of the first and second housing part 30', 30" form a window for the temperature sensor 34.
[0084] The temperature sensor 34, in this example an infrared sensor, is held behind this window 302, 302', in a respective receptacle formed by the housing 30, preferably in a form-fitting manner. An infrared transmissive plastic film 340 is placed in front of the infrared sensor 34.
[0085] The plug 32 comprises connector pins 320 which can be plugged into sockets of an electrode connector 39. The electrode connector 39 is held in a passage 303 of the handset housing 30.
[0086] A first wire 370 or first wires connect the electrode connector 39 with the electronic module 36, as can be seen in figure 3. A second wire 371 or second wires connect the temperature sensor 34 with the electronic module 36. A third wire 372 or third wires connect the actuator 38 with the electronic module 36. By manually actuating the actuator 38, the electronic module 36 enables initiation at the control unit 10 which starts the applicator, i.e. applies an RF frequency to the electrodes 33. In preferred embodiments, the temperature sensor 34 is active when the control unit 10 is started. In other embodiments, the temperature sensor 34 is activated by the actuator 38. In other embodiments, the temperature sensor 34 is activated when the control unit 1 is started.
[0087] In this embodiment, the applicator 31 comprises exactly two electrodes 33. The electrodes 33 have the same shape and size and they are made of the same material. The two electrodes 33 are identical. Preferably, they are massive, i.e. they are solid not hollow and they do not comprise some free space in their interior. Preferably, they have a circular crosssection.
[0088] As can best be seen in figures 5 and 6, each electrode 33 comprises a first leg and a second leg extending at an angle to each other. The first leg comprises a plug sided end 330 and a protruding part 331. The plug sided end 330 has a smaller diameter than the protruding part 331. The plug sided end 330 is fixed in the plug 32. The protruding part 331 protrude the plug 32 and the handset housing 30. The longitudinal axis of the protruding part 331 extends preferably in the longitudinal direction of the handset housing 30. The second leg extends in an angle to the handset housing 30 and forms an applying part 332. The free end of the second leg is preferably rounded. The first leg and / or the second leg are preferably straight. With exception of the plug sided end 330 and the rounded end 333, the electrode 33 has preferably the same thickness and the same cross-section over its entire length.
[0089] Preferably, the length of the plug sided end is about 6 mm, the straight protruding part 331 is about 10 mm, the angle is about 47° and the length of the applying part is about 19 mm. The diameter of the applying part 332 is about 2 mm. The distance between the two electrodes, measured between their surfaces, is about 4 mm.
[0090] Figure 7 shows, in a schematical way, an enlarged top view of a part of the plug 32 and the two electrodes 33 applied on a patient's skin. A region of the patient's skin is marked with reference number 5. The applying parts 332 of the two electrodes 33 are laid, or even held, onto the patient's skin.
[0091] When the treatment device is active, the RF energy applied through the two electrodes 33 into the patient's skin heat an area of the skin, the area being located between the two electrodes and in the neighbouring area. The heating zone is marked in figure 7 with dots and reference number 50.
[0092] The temperature sensor 34, in this example the infrared sensor, is located such in the handset 3, that its measurement zone 4 is located between the two applying parts 332 of the two electrodes 33. The measurement zone 4 in this embodiment is an ellipse. Other shapes are possible. Preferably, the measurement zone 4 covers almost the whole length of the applying parts 332 of the electrodes 33. Preferably, it does not extend over the electrodes 33 and / or outside the length of the applying parts 332.
[0093] Tests have shown that the temperature in the heating zone 50 is quite uniform. This can be seen in figure 8. Figure 8 shows the temperature of a human skin measured with an infrared camera. The temperature between the two electrodes is quite uniform. The gaps (valleys or trough) on both side by about 3 and -3 mm are the location of the electrodes.
[0094] These uniform heating ensures a uniform treatment of the skin or tissue. In addition, it helps to control the heat generated in the skin and it therefore avoids burns or undertreatment.
[0095] Figure 9 shows the temperature of a porcine skin during ramp-up of the inventive treatment device, called DermatoTherma, compared with the ramp-up of a state-of-the-art treatment device, which is the ThermoMed device. During ramp-up, the ThermoMed device generates some overheating until it can reduce to the treatment temperature. The reason by be the delay, loss and / or inconsistency in temperature measurement. The inventive device however increases the temperature continuously until it reaches the required treatment temperature.
[0096] Figure 10 shows a block diagram of the RF module 6 of the control unit 10. The RF module 6 is arranged in the housing 10 of the control unit 1. The RF module 6 comprises an oscillator 60, a signal preprocessor 61 , an RF modulator 62 including a power amplifier and a voltage regulator, a filter 64 and an interface 65 to the handset 3. The control unit 10 also comprises a micro-controller 7 for controlling the RF modulator 62 and the voltage regulator of the RF module 6 in according to the feedback of the temperature sensor 34. The voltage regulator of the RF module 6 is preferably a step-down regulator, i.e., the output voltage is equal or less than the input voltage.
[0097] Figure 11 shows a block diagram of the handset 3. The block diagram shows the features of the electronic module 36, the module connector 360 and the temperature sensor 34. A thermopile 80 converts thermal energy of the temperature sensor 34 in electrical energy. A voltage regulator 81 regulates the supply voltage of the temperature sensor 34 according to signals received by a connector 83, which is connected to the control unit 10. A switch 82, which is activated by the actuator 38, or which is the actuator 38, activates the handset 3 so that RF energy is applied to the electrodes 33 from the control unit 10 by the connector
[0098] 83.
[0099] Figure 12 shows a flowchart depicting the security control routine of the control unit 10. It is checked step by step if the power supply works, the status of the battery, whether the temperature sensor is working, if the applicator is onto the skin (i.e. load detected), if the ramp-up time is longer than a given value, if overcurrent is detected and if the treatment temperature, i.e. the temperature measured by the temperature sensor, is within a specified range. If the responses are not satisfying, the treatment will be aborted and an error message will be displayed or otherwise notified by the control unit.
[0100] Figure 13 shows a flow chart depicting the ramp-up and operation mode of the control unit. When the control unit is powered up, the hardware is initialized. When the start button at the handset is pressed, it is checked if the application is already running, i.e., the system and the skin is already heated up in a previous treatment. If yes, the treatment electrodes and therefore the RF energy applied is just hold at the level used before. If no, ramp-up is started until the treatment temperature is reached. When the treatment temperature is reached, the temperature is held until the treatment is competed.
[0101] Figure 14 shows a flow chart depicting the updating of the control unit with new data. This routine is preferably performed by the control unit each time the treatment is started, i.e., the button 38 got pressed. The controller 7 of the control unit then checks if the hardware readings include new data. If new hardware readings or data are present, the values are updated. It is then checked, if the system works at a safe operating point and it is only proceeded, when this is fulfilled. The controller 7, preferably a PID, is updated (PID controller = Proportional- integral-Differential Controller). Output is written and when the treatment is complete, the treatment is stopped.
[0102] In preferred embodiments, not only the temperature of the skin is measured, but a modelbased algorithm a is used to assess the temperature distribution in deeper layers of the skin. The radio frequency energy output is adjusted according to measured parameters, such may be surface temperature and skin impedance This is done by the controller 7 of the control unit 10. In preferred embodiments, the application area, i.e. the treatment zone, is modified according to treatment needs and control parameters adjusted by the control unit.
[0103] A control loop of the control unit preferably takes three measured inputs and evaluates them in a control algorithm. The three measured inputs are the detected power output, the measured temperature and the measured impedance. The power output is regulated in the RF Module according to the control unit output. The control loop is preferably achieved with a parallel resonant circuit topology chosen for the filter. This incorporates the cable and skin capacitance as integral components of the resonant circuit. This design approach allows for effective inclusion and utilization of these capacitances in the overall circuit performance.
[0104] Furthermore, a transformer is preferably included prior to routing the RF signal through the cable. This serves two purposes: galvanic separation and generation of a differential RF signal. The transformer ensures electrical isolation between the source and the cable, preventing any potential ground loops or interference. Additionally, it enables the creation of a differential RF signal, which offers improved noise immunity and enhanced signal integrity.
[0105] The control unit 10 is a quite simple but efficient device, which ensures a reliable and safe treatment at a reasonable price. The RF module 6 is controlled by a main module comprising the micro-controller 7. Preferably, the RF module 6 does not comprise a component running a software. The RF module 6 executes commands and prepares the responses to the micro-controller 7.
[0106] LIST OF REFERENCE SIGNS control unit film housing 35 screw control means 350 locknut display 351 fixation plate
[0107] 36 electronic module supply line 360 module connector
[0108] 370 first wire handset device 371 second wire handset housing 372 third wire ' first housing part 38 actuator " second housing part 39 electrode connector0 indentation 1 first receptacle part 4 measurement zone1' second receptacle part 2 first window part 5 skin region 2' second window part 50 heating zone 3 passage 4 bush 6 RF module 5 fixation plate 60 oscillator 6 screw 61 signal preprocessor7 locknut 62 RF modulator and power8 through-opening amplifier 9 end face opening 64 filter applicator 65 interface Plug electrode 7 micro-controller 0 plug-sided end 1 protruding part 80 thermopile 2 applying part 81 voltage regulator3 free end 82 switch temperature sensor 83 connector 0 infrared transmissive plastic
Claims
CLAIMS1. A treatment device for skin or tissue treatment with radiofrequency (RF) energy, the device comprising a control unit (10) and a handset device (3), wherein the handset device (3) comprises a handset housing (30) and an applicator (31), wherein the applicator (31) comprises two elongate electrodes (33) to be applied to the skin or tissue to be treated, wherein the treatment device comprises a temperature sensor (34) for detecting a temperature at a treatment site, wherein the control unit (10) controls the RF energy according to the detected temperature at the treatment site, characterized in that the temperature sensor (34) is a contactless sensor.
2. The treatment device of claim 1 wherein the temperature sensor (34) is arranged such that it measures an area (4) between the two electrodes (33).
3. The treatment device of claim 2 wherein the temperature sensor (34) is arranged such that it measures exclusively between the two electrodes (33) except a periphery of the two electrodes (33).
4. The treatment device of claim 2 wherein the temperature sensor (34) is arranged that it measures exclusively between the two electrodes (33) with a distance to the two electrodes (33).
5. The treatment device of any one of claims 1 to 4 wherein the two electrodes (33) are identical.
6. The treatment device of any one of claims 1 to 5 wherein the two electrodes (33) are operated simultaneously and identically.
7. The treatment device of any one of claims 1 to 6 wherein the two electrodes (33) are massive, which means not hollow.
8. The treatment device of any one of claims 1 to 7 wherein each of the two electrodes (33) comprises a first leg (330, 331) connected to the handset housing (30) and extending from the handset housing (30) and a second leg (332, 333) extending at an angle to the first leg (330, 331), wherein at least the second legs (332, 333) of the two electrodes (33) extend parallel to each other and wherein the second legs (332, 333) of the two electrodes (33) are suitable to be applied to the skin or tissue to be treated simultaneously.
9. The treatment device of claim 8 wherein the second legs (332, 333) extend in a straight line.
10. The treatment device of claim 8 or claim 9 wherein the second legs (332, 333) are suitable to be applied to the skin or tissue to be treated along their whole length.11 . The treatment device of any one of claims 1 to 10 wherein the two electrodes (33) define an area to contact the skin or tissue to be treated simultaneously, wherein the area is preferably about 70 mm2to 80 mm2and more preferably about 76 mm2or about 19 mm to 4 mm.
12. The treatment device of any one of claims 1 to 11 wherein exactly two electrodes (33) are present.
13. The treatment device of any one of claims 1 to 12 wherein the temperature sensor (34) is an infrared sensor.
14. The treatment device of any one of claims 1 to 13 wherein the temperature sensor (34) is arranged in the handset device (3) at a distance to the two electrodes (33) and located in a middle axis between the two electrodes (33).
15. The treatment device of any one of claims 1 to 14 wherein the temperature sensor (34) is arranged in the handset housing (30).
16. The treatment device of any one of claims 1 to 15 wherein the applicator (31 ) comprises a plug (32) holding the two electrodes (33) and wherein the plug (32) is removable connectable to the handset housing (30).
17. The treatment device of any one of claims 1 to 16 wherein the control unit(10) comprises means for obtaining three inputs and wherein the control unit (10) comprises a control algorithm for evaluating the three inputs, wherein the three inputs are power output, measured temperature and measured impedance.
18. The treatment device of claim 17 wherein the control unit (10) comprises means to measure a first voltage across the electrodes (33) and a second voltage being the drop across a shunt resistor in a current path leading back from the electrodes (33) to the control unit (10) and means for comparing curves of the first and second voltage by use of a phase locked loop, resulting in a voltage depending on the phase angle.
19. The treatment device of claim 17 or claim 18 wherein the control unit (10) comprises means to deduct the impedance of at least some parts of an electronic circuit of the control unit from the measured impedance in order to obtain a corrected impedance, wherein this corrected impedance is used as one of the three inputs.
20. The treatment device of any one of claims 17 to 19 wherein the impedance is measured between the two electrodes at a first frequency.21 . The treatment device of claim 20 wherein the treatment device is capable of being operated at least one second frequency being different to the first frequency and wherein at least one second impedance is measured at the at least one second frequency.
22. A use of the treatment device according to any one of claims 1 to 21 for treating Cutaneous Leishmaniasis.
23. A method for operating the treatment device according to one of claims 1 to 21 wherein the method comprises applying RF energy to two elongate electrodes (33), using a contactless temperature sensor for detecting a temperature at a treatment site and controlling the RF energy according to the detected temperature at the treatment site.
24. The method according to claim 23, the method comprising the step of obtaining three inputs and evaluating the three inputs in a control algorithm, the three inputs being power output, measured temperature and measured impedance, and the step of controlling the RF energy applied to the two electrodes (33) based on the evaluation of the three inputs.
25. The method according to claim 24 wherein in order to obtain the three inputs a first and a second voltage are measured, wherein the first voltage is a voltage across the electrodes (33) and a second voltage is a drop across a shunt resistor in a current path leading back from the electrodes (33) to a control unit (10), and wherein curves of the first and second voltage by use of a phase locked loop are compared in order to obtain a voltage depending on the phase angle, thereby using this voltage to control the RF energy applied to the two electrodes.
Citation Information
Patent Citations
Head-gimbal assembly with trace configured to reduce stress on a microactuator and disk drive including the head-gimbal assembly
US20110096438A1
Hyperthermia treatment systems and methods
US8306629B2
Hyperthermia Treatment Systems and Methods
US20090118802A1
A safe skin treatment apparatus for personal use and method for its use
US20150328474A1
Radio-frequency treatment of skin tissue with temperature sensing
US8321031B1
